Tous Actualités
Suivre
Abonner Agendia B.V.

Agendia B.V.

Agendia to Present at BioCentury's Future Leaders in the Biotech Industry Conference

Huntington Beach, California and Amsterdam (ots/PRNewswire)

Agendia, a world leader in molecular cancer diagnostics, today
announced that the Company is scheduled to present at the 16th
Anniversary "Future Leaders in the Biotech Industry" Conference on
Thursday, April 2, 2009. Presented by BioCentury and Thomson Reuters,
the Future Leaders conference has built a reputation as a major
biotech investment event, matching strong companies with a select
group of specialized institutional investors, investment bankers,
sellside/buyside analysts, and pharmaceutical licensing executives.
    Agendia's BioCentury Presentation details are as follows:
    Event: BioCentury / Thomson Financial "Future Leaders in the Biotech
    Industry"
    Presenter: Dr. Bernhard Sixt, President & CEO
    When: Thursday, April 2, 2009 at 1:30 - 1:55 p.m.
    Breakout Session: 1:55 - 2:55 p.m., Room 502
    Where: Millennium Broadway Hotel, New York City, Room 502/303
    Address: 145 West 44th Street, New York, NY, 10036
About Agendia
Agendia is at the forefront of the personalized medicine
revolution, striving to bring more effective, individualized
treatments within reach of patients. Building on a cutting edge
genomics platform for tumor gene expression profiling, the company's
tests aim to help physicians more accurately tailor cancer
treatments. The company markets four products, with several new
genomic tests under development. In addition, Agendia collaborates
with pharmaceutical companies to develop highly effective
personalized drugs in the area of oncology. Agendia is based in
Huntington Beach, California, and in Amsterdam, The Netherlands. For
more information please visit http://www.agendia.com.

Contact:

Media contacts: Hans Herklots, Head of Corporate Communications,
+31-20-462-1557 Office, +31-620-083-509 Cell,
hans.herklots@agendia.com; Valerie Delva, Ricochet Public Relations,
+1-212-679-3300 x131 Office, +1-917-975-3191 Cell,
vdelva@ricochetpr.com

Plus de actualités: Agendia B.V.
Plus de actualités: Agendia B.V.